STI Eases 0.19% From Record; REITs Lead, Property Lags
The Straits Times Index closed 0.19% lower at 5,498.95 on Monday, easing from last week's record high of 5,561.42. Gains in large-cap REITs and steadier bank shares were outweighed by weakness across property counters. Trading was subdued ahead of the local earnings season.
The decline was modest and not driven by any single macro event. With no fresh overseas lead and results season still days away, the index met resistance near last week's peak and saw some profit-taking. Activity reflected rotation within the market — toward yield and defensive names — rather than broad selling.
Session Movers
Mapletree Pan Asia Commercial Trust (N2IU.SG, +0.75%) was the most actively traded stock and the top gainer among index constituents. The REIT trades at 0.76 times book value with a distribution yield near 6%, and the consensus analyst target of S$1.52 implies about 13% upside. Its manager said non-executive director Wendy Koh will step down on 30 July.
OCBC (O39.SG, +0.46%) rose after bank shares steadied from two days of declines, helped by an active local funding market — Singapore mandated five banks for a S$1.63 billion 20-year green bond — and a reiterated Buy from UOB Kay Hian. It trades at 2.06 times book value, near a five-year high, and its consensus target of S$26.99 is about 6% below the current price.
Hongkong Land (H78.SG) was among the weakest index stocks, alongside developer UOL. It trades at 0.52 times book value and yields about 3%, and recently cancelled 480,000 shares repurchased from the market. Property stocks broadly underperformed.
One point worth noting
The bank shares that have led the STI to its recent record are trading at multi-year valuation highs. DBS is at 2.97 times book value and OCBC at 2.06 times, both near five-year peaks, according to Longbridge data. Much of the index's advance has rested on a small group of large — and now richly valued — financials.
This recap is for informational purposes only and does not constitute investment advice.